Medication Assisted Treatment

Similar documents
Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

Opioid Treatment in North Carolina SEPTEMBER 13, 2016

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

Medication-Assisted Treatment (MAT) Overview

Treatment Alternatives for Substance Use Disorders

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Buprenorphine pharmacology

Treatment Approaches for Drug Addiction

MEDICATION ASSISTED TREATMENT

Closing the Loop in Treating Opioid Addiction:

Treatment Team Approaches in Substance Abuse Treatment

Disclosures. Topics of today s training 4/24/2017. Evolving Treads in Medication Assisted Treatment. Christopher J Davis D.O.

Understanding and Combating the Heroin Epidemic

Helping Recovery Residences Adapt

Vivitrol Drug Court and Medication Assisted Treatment

Methadone and Naltrexone ER

Charles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus

Talking with your doctor

Building Community Coalitions to Address the Opioid Crisis

Pragmatic and Creative Responses to the Opioid Crisis in Connecticut

The Social Worker s Role in Medication Assisted Treatment

Addiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer

Opiate Use Disorder and Opiate Overdose

Building capacity for a CHC response to Ontario's Opioid Crisis

Medicaid and the Opioid Crisis

Patient and Family Agreement on Opioids

Medication Assisted Treatment as an alternative in Drug Courts*

THE STATE OF MEDICINE IN ADDICTION RECOVERY

Prescription Opioids

Naltrexone protocol alcohol

Revised 9/30/2016. Primary Care Provider Pain Management Toolkit

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

Medications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC

AODA RECOVERY. How to support those in recovery, and those not yet ready to commit

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc.

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment

2/21/2018. What are Opioids?

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery

DHCS Tribal MAT Project

Changing Course: statewide efforts to combat the opioid epidemic in California

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry

HARM REDUCTION & TREATMENT. Devin Reaves MSW

Pharmacotherapy for opioid addiction. Judith Martin, MD Medical Director BAART Turk Street Clinic San Francisco

2004-L SEPTEMBER

NURSING FOLLOW-UP: BUPRENORPHINE/NALOXONE BUPRENORPHINE/NALOXONE CLINIC VISITS

Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations

Opioid Dependence and Buprenorphine Management

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

TELEPHONE SCREENING DEMOGRAPHIC INFO

Opioid Task Force Kick-Off Meeting. February 29, 2016

Understanding the Opiate Epidemic

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

CHANGING CULTURE, BUILDING A SYSTEM, SUPPORTING PATIENTS AND STAFF. Andrew Suchocki, MD, MPH Medical Director Clackamas Health Centers

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

The Unseen Consequences of Prescription Drug Abuse. Stephen Loyd, M.D.

Aetna s Initiative on the Opioid Epidemic

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

Recovery U: Medication Assisted Treatment (MAT)

Anyone Can Become Addicted. Anyone.

THA Medication Safety Summit. Wesley Geminn, PharmD, BCPP

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

RECOMMENDATIONS FOR HEALTH CARE PROVIDERS

Addiction Medicine: What s new for primary care

Identification and Treatment of Opioid Use Disorders in Primary Care Settings

Brief History of Methadone Maintenance Treatment

STRONGER THAN VICODIN PAIN KILLERS

1) To understand the scope of the opioid epidemic with relation to Emergency Departments 2) To gain insight into some emerging Emergency Medicine

mcmillenhealth.org Linda Hathaway, C.F.C.S.

Opioid Use Issues: All the Players

Opioid Use Disorders &Medication Treatment

Opioid Prescription and Illicit Drug Overdoses: On the Rise

Opioid Use in Youth. Amy Yule M.D. March 2,

Stark County Opiate Task Force

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008

State Opioid Response (SOR) Grant

Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP

Medicated Assisted Treatment

Pharmacotherapy for Addiction A Practical Guide

Overview of Medication Assisted Treatment Methadone, Buprenorphine and Naltrexone

Buprenorphine & Controlled Substance Treatment Agreement

Today s workshop is sponsored by BSAS

7/7/2016 Journal of the American Medical Association,

HEALTHWEST. Procedure. No Prepared by: Effective Date: June 1, 2017 Revised Date: November 13, 2018 Cyndi Blair, RNBC Chief Clinical Officer

Strategies to Manage The Opioid Crisis

Methadone and Naltrexone ER

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

A prisoners guide to buprenorphine

Take Home Naloxone elearning Module Script

4/5/2018 MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDERS OBJECTIVES DEFINITION OF ADDICTION APRIL 11, 2018 RITU BHATNAGAR, M.D., M.P.H.

8/28/2017. Headlines. How Did We Get Here? Pain is the number one reason patients go the doctors office, urgent care and/or emergency room.

Rationale & Strategy For Integrating Buprenorphine Treatment Into Community Health Centers

Opioids Research to Practice

Second of two articles

How To Engage and Keep Youth and Families in Treatment: Focus on Opioid Use and Abuse

5/29/2015. Responding to the Opioid Crisis. Responding to the Opioid Crisis. Objectives

How serious is the opiate problem in Fairfield County?

Transcription:

Meeting the Needs of Your Clients: Building Competencies in Mental Health and Addiction Services Medication Assisted Treatment November 5, 2018 In partnership with:

House Keeping Because this is a webinar, attendees are muted Please type any questions you have into the Questions Box We are recording this webinar and will send out the link to everyone who registered at a later date. Type in questions below

Shelly A. Nolan, MS, LPC Director of Women s Services Department of Mental Health & Addiction Services

Shelly A. Nolan, MS, LPC Director of Women s Services Department of Mental Health & Addiction Services

What we know The opioid epidemic is impacting all 50 states Substance use disorders impact all races, ages, genders, and economic classes The problem is getting bigger and as a result more lives have been lost Addiction is a disease like any other medical problem but it is often viewed differently

The CT epidemic

What are opioids Narcotic Medications used to treat and manage pain Common Names- Percocet, Oxycodone, Vicodin, Dilaudid, Codeine, etc. Pain scales Initially intended to be used short-term or for individuals with terminal illness People are prescribed these medication but not always educated on the high risk of addiction potential Some people have a harder time ending use than others

What happens when your doctor stops prescribing? Other people take opioid medications prescribed to someone else Sharing medications- here try this, it may help Safe storage & disposal Heroin Cheaper to buy on the street than prescription medications and more accessible You never know what you re getting often mixed with other substances Fentanyl

Recovery Orientation Language has power Substance use disorder vs. abuse or dependence The word addict Sometimes embraced within the recovery community however not appropriate within the treatment realm Recovery is a journey not an event Stigma Documentation follows the client Advocate for fact based, neutral & objective writing

What is MAT? SAMSHA defines MAT as: Medicated-Assisted Treatment (MAT) is the use of FDAapproved medications, in combination with counseling and behavioral therapies, to provide a whole-patient approach to the treatment of substance use disorders. https://www.samhsa.gov/medication-assisted-treatment

How does MAT help? Blocks opioids from accessing opioid receptors in the brain (partially or fully) Prevents withdrawal and cravings Increases positive birth outcomes for pregnant women If mom has withdrawal symptoms, so does baby which can lead to miscarriage Mom is connected to treatment with increased support Decrease illicit drug use Results in reduced risk of HIV, Hepatitis C and other infections Research shows that the mortality rate of untreated individuals using heroin is 15 times higher compared to individuals receiving methadone maintenance treatment (who have a similar mortality rate to the general public) *Source: Beacon Health Options White Paper on Opioid Crisis

Stages of Change

MAT Myth Busting Clients on methadone often nod out or seem drowsy Clients on MAT have no reason to use & can still get high The lower the dose, the better They should just be able to stop Isn t MAT replacing one addiction for another It s harder to kick methadone than heroin Methadone rots your bones and teeth MAT is forever, the person will never be drug free

Medication Assisted Treatment A key component to combating the opioid epidemic Naltrexone (Vivitrol) Buprenorphine (Suboxone) Methadone Opioid Addiction

Methadone Prescribed out of a federally regulated Opiate Treatment Program (OTP) which requires an individual to present to a clinic each day when they start and engage in monthly treatment (urine screenings, group/ individual counseling) Prevents onset of withdrawal symptoms for 24 hours Full opioid agonist. When on a stable therapeutic dose, you will not get high from illicit opioids When properly managed, it s a very safe medication with minimal side effects

Buprenorphine (Suboxone/ Subutex) Person can be prescribed medication by a doctor who has received specialized training May be PCP or in a behavioral health setting Sublingual film or tablet taken daily which reduces cravings to use Buprenorphine is an opioid partial agonist. This means that, like opioids, it produces effects such as euphoria or respiratory depression. These effects are weaker than those of full drugs such as heroin and methadone Best course of action is medication in combination with other support (group or individual therapy) Less overdose risk when using formulation combined with naloxone

Naltrexone (Vivitrol) Comes in pill form or more commonly in a monthly injectable Blocks the euphoric and sedative effects of opioids Unlike other MAT formulations, it activates the opiate receptors to reduce cravings If a person were to use an opioid, they would need to use more than normal to override the naltrexone putting them at an increased risk of overdose

One size does not fit all As with any medication, there are pros and cons to each type of MAT It s best for each person to discuss their history, current use, and goals for recovery with their prescriber so that an individualized plan can be tailored to them If at first you don t succeed, try something else

Alcohol Disulfiram/ Antabuse If person uses alcohol they will become ill Person needs to be committed to recovery Acamprostate/ Campral Daily medication to decrease cravings to use alcohol by restoring chemical balance in the brain Should be prescribed following detox or once use has been stopped Naltrexone/ Vivitrol Monthly injection aimed at reduces cravings to use Person must have a period of not using prior to starting

Nicotine Prescription medication used to limit cravings and reduce nicotine withdrawal symptoms Chantix, Zyban Over the counter nicotine replacement therapy in the form of patches, gum, lozenges, inhaler, Etc. Person starts at a dose and tapers down over time

Naloxone (Narcan) Prescription medication that reverses an opioid overdose Can be obtained at pharmacies throughout CT without a doctor s prescription and is covered by many insurance plans Should be on hand at any program where individuals with an opioid use disorder may be https://www.ct.gov/dmhas/cwp/view.asp?q=509650

Connection to care CCAR Telephone Support Line https://ccar.us or 866-205-9770 Access Line Information on walk-in assessment centers throughout the state at www.ct.gov/dmhas/walkins or 1-800-563-4086 Screening & Warm hand off to detox services Enhancement to provide transportation services statewide, when appropriate, to detox and between residential settings as of July 1, 2017 Beacon Health Options Resources http://www.ctbhp.com/medication-assistedtreatment.html Includes Interactive Map of all MAT providers

Presenter Contact Info Shelly Nolan, MS, LPC, Director of Women s Services Phone: 860-262-6605 Email: shelly.nolan@ct.gov

Questions? For additional questions, contact Shelly at shelly.nolan@ct.gov

Resource Substance Use Services Resource Page Meeting the Needs of Your Clients: Building Competencies in Mental Health and Addiction Services Upcoming Webinars December 10 January 14 February 11 March 11 April 8 A Guide to Crisis Prevention and De-Escalation Inspiring Internal Motivation: A Short Guide to Motivational Interviewing Adopting a Cultural Humility Approach Addressing Reproductive Health in Women Experiencing Homelessness Addressing the Needs of Older Populations Facing Homelessness Contact training@cceh.org for more information